In cases of repeated abortions, is lesser dose of heparin effective in preventing abortion.

Screening for inherited thrombophilia in recurrent pregnancy loss and role of therapy with aspirin and low molecular weight heparin (LMWH).

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013167

Enrollment

Registered

2018-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with recurrent pregnancy loss

Interventions

Intervention1: Low molecular weight heparin 20mg: Low molecular weight heparin 20mg subcutaneous once daily plus oral aspirin 75 mg once daily till 34 weeks Control Intervention1: Low molecular weight

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with history of previous 3 or more consecutive abortions

Exclusion criteria

Exclusion criteria: Other causes of RPL

Design outcomes

Primary

Measure	Time frame
Pregnancy outcome in terms of abortion rate and live birth rateTimepoint: At delivery	—

Secondary

Measure	Time frame
History of bleeding during pregnancy Choriodecidual hemorrhage Gestational age at delivery Adverse eventsTimepoint: At delivery	—

Countries

India

Contacts

Public ContactNutan Agarwal

AIIMS New Delhi India

nutan_agarwal@yahoo.com9810107464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026